Early gestation, but not mid- or late gestation, has been identified as a critical period for these alterations, mostly related to genes implicated in growth, development, and metabolism.
In the free-living stages, domains previously implicated in growth and development tended to dominate.
Domains previously implicated in growth and development such as chromo domains and the MADF domain tended to dominate in the free-living stages.
LPS causes growth arrest in macrophages, and other Slfn family genes have been implicated in growth control.
The type 1 Insulin-like Growth Factor Receptor (IGF-1R) belongs to the RTK superfamily and mediates crucial signaling pathways implicated in growth, proliferation, differentiation and apoptosis.
Ghrelin activates GH release and is implicated in growth and metabolic regulation.
A number of studies have implicated transforming growth factor (TGF -β1, 2, and 3 (TGF -β1in wound healing and hypertrophic scarring.
Several reports have suggested that cell-surface nucleolin is implicated in growth of tumor cells and angiogenesis [2], [15], [16].
Previous in vivo studies have implicated fibroblast growth factor (FGF) signalling in lineage specification from pluripotent cells.
Emerging evidences suggest that nucleolin expressed on the cell surface is implicated in growth of tumor cells and angiogenesis.
